Discussion with Kurt Rasmussen

The Mu Chapter of Sigma Pi Educational Foundation’s fall program is sponsoring a talk with Dr. Kurt Rasmussen, PhD.

Dr. Rasmussen is an internationally recognized neuroscientist, who specializes in basic addiction research and drug development. Dr. Rasmussen has extensive knowledge of neuropsychiatric and neurological therapeutics and is known for his expertise in pharmaceutical discovery research from hypothesis generation to clinical candidate evaluation. As director of the Division of Therapeutics and Medical Consequences, Dr. Rasmussen directs NIDA’s Medications Development Program, evaluating the safety and efficacy of pharmacotherapies, behavioral therapies, and devices to treat substance use disorders through peer reviewed grants, contracts, and interagency agreements. Prior to joining NIDA, Dr. Rasmussen served as a senior research advisor, leading drug discovery research programs at Eli Lilly & Co.

The fall speaker program is designed specifically for the undergraduates by the Mu Chapter of Sigma Pi Educational Foundation in light of the recent policy initiatives by Cornell to curb risky behavior and, through education, to promote a safer environment for the undergraduate brothers and guests of the house.